THE FETTE COMPACTING EFFICIENCY GUIDE
The Fette Compacting Efficiency Guide is the guidance System for our entire product and service range.
Merck in China
TARGET: TEN BILLIONS
Merck’s second largest pharmaceutical production site is currently taking shape on the east coast of China, just around a two-hour drive away from Shanghai. When the factory reaches full capacity in 2021, plans call for the production of ten billion tablets a year in Nantong. The tablet presses required to achieve this come from Fette Compacting.
STABILITY TO THE 4TH POWER
Besides EU and TSM formats Fette Compacting offers FS® punches. As
an alternative, these punches offer longer tool lives and even smoother running. There is now a link between these two, formerly separate, “format worlds“: Fette Compacting introduces the EU 19 FS® as a new generation of punches at the trade fair “components”, which accompanies the interpack in Düsseldorf.
THE FUTURE OF THE CAPSULE MARKET
Sven Stegemann is Director for Pharmaceutical Business Development at Capsugel. Within this role he is leading common research projects with all major pharmaceutical as well as SME companies on a global base. He holds a PhD in pharmacology and is an endowed professor for patient-centric drug development and manufacturing at Graz University of Technology in Austria. Mr Stegemann worked in different roles of the pharmaceutical product. We asked him several questions about the future of the capsule market.
PHARMAMARKT 2020: UPSWING TURN FOR GLOBAL PRODUCTION
According to current studies, pharmaceutical producers can look forward to growing demand in the years to come. Growth means that more people receive access to medical care on the one hand while special medication for rare diseases gains in importance on the other. This increases international requirements on flexibility and quality in production.
Machine technology is obliged to offer the right solutions for each product and each requirement – increasingly in accordance with uniform global standards. In an interview, Rainer Krugmann, Global Director Sales at Fette Compacting, provides an outlook as to what trends Fette Compacting can anticipate in the production of solid formulations.
„MORE VEGETARIAN AND ORGANIC CAPSULES”
Scott Anderson, as Director of Operations for Standard Process, leads the overall strategic direction of the manufacturing, distribution, supply chain and engineering functions as well as a 1,000 acre farming operation for the company. Based in Palmyra, Wisconsin, Standard Process is one of the leading companies in food nutrient solutions. The company has been in business since 1929 and offers more than 300 different supplements today. In an interview with What's Next? Anderson explains the role of capsules in the nutrition industry and what challenges come to manufacturers.
FAST, INDIVIDUAL, DIGITAL: WHAT CUSTOMERS EXPECT OF GLOBAL SUPPORT
Trade fairs such as the Interphex 2016 are more than mere platforms for presenting new machinery. They also offer the opportunity to exchange information with regard to current requirements on technical support and consulting. In New York City, Fette Compacting will be availing of the opportunity to interact with American and international pharmaceutical customers in order to find out what they expect of a machine manufacturer: from individual service through around-the-clock availability to secure digital networking. Insights into this issue are provided by Lars Plüschau, Director Global Customer Support.
THE FEC40: A NEW CLASS OF HARD CAPSULE FILLING
What expectations do users have of a next-generation capsule filling machine? How productive and efficient should it be? What should it offer to ensure that users can work optimally with this machine? These were the questions asked by our engineers in the development of the first capsule filling machine produced by Fette Compacting. The result is a premiere in the world of pharmaceutical manufacturing: with a production output of up to 400,000 capsules per hour, the FEC40 sets new standards in the efficiency of capsule filling machines.
CONTINUOUS MANUFACTURING: MONTHS BECOME HOURS
Product approval in real time? Producers of pharmaceuticals and machine manufacturers worldwide are working on this vision. Thanks to Continuous Manufacturing (CM), delays attributable to separate production processes, complex conversions and long offline analyses could soon be a thing of the past. Pilot plants are already available but it’s still early days for technology in the area of commercial pharmaceutical production. In an interview, Dr. Martin Schöler from Fette Compacting outlines the discoveries made by these pilot projects and how the CM vision is to become a reality.